Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GBP511
- Development stage
- Phase 2
- Lead developer
- SK bioscience
- Modality
- Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
GBP511 is a universal coronavirus (pan-sarbecovirus) vaccine candidate developed by SK bioscience in collaboration with the University of Washington's Institute for Protein Design. It utilizes self-assembling protein nanoparticle technology to present viral antigens, specifically targeting the sarbecovirus family to provide broad protection against SARS-CoV-2 and related viruses. The program is supported by the Coalition for Epidemic Preparedness Innovations (CEPI) and is being evaluated in Phase 1/2 clinical trials, often in combination with the adjuvant CAS-1.
- Other names
- pan-sarbecovirus vaccineuniversal coronavirus vaccineSK bioscience universal coronavirus vaccine
02
Targets
BCR (Immunoglobulin G B Cell Receptor)T-cell receptor recognizing Guanylate-binding protein 5-derived peptides
Beyond the preview
Go deeper on GBP511.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GBP511.